NO20071139L - Farmasoytisk preparat med langvarig frigivelse omfattende venlafaxin - Google Patents

Farmasoytisk preparat med langvarig frigivelse omfattende venlafaxin

Info

Publication number
NO20071139L
NO20071139L NO20071139A NO20071139A NO20071139L NO 20071139 L NO20071139 L NO 20071139L NO 20071139 A NO20071139 A NO 20071139A NO 20071139 A NO20071139 A NO 20071139A NO 20071139 L NO20071139 L NO 20071139L
Authority
NO
Norway
Prior art keywords
venlafaxine
pharmaceutical composition
prolonged
release pharmaceutical
dispersion
Prior art date
Application number
NO20071139A
Other languages
English (en)
Inventor
Silvo Zupancic
Robert Pisek
Zakelj Mojca Segula
Original Assignee
Krka Tovarna Zdravil Dd Novo M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil Dd Novo M filed Critical Krka Tovarna Zdravil Dd Novo M
Publication of NO20071139L publication Critical patent/NO20071139L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er beskrevet en fremgangsmåte for fremstilling av et farmasøytisk preparat inneholdende venlafaxin eller et farmasøytisk akseptabelt salt derav, som omfatter trinnene med (1) fremstilling av en dispersjon av venlafaxin eller et venlafaxinsalt i et oppløsningsmiddel hvori venlafaxinet eller venlafaxinsaltene har en oppløselighet på mindre enn 25 g/l ved romtemperatur; (2) omdanning av dispersjonen fra trinn (1) til partikkelform; (3) belegging av partiklene oppnådd i trinn (2) med et lag av polymer med langvarig frigivelse, så vel som farmasøytiske preparater som kan oppnås ved denne fremgangsmåten.
NO20071139A 2004-07-28 2007-02-28 Farmasoytisk preparat med langvarig frigivelse omfattende venlafaxin NO20071139L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004036641A DE102004036641A1 (de) 2004-07-28 2004-07-28 Verzögert freisetzende pharmazeutische Zusammensetzung, die Venlafaxin enthält
PCT/EP2005/008149 WO2006010605A2 (en) 2004-07-28 2005-07-27 Sustained release pharmaceutical particulate composition comprising venlafaxine

Publications (1)

Publication Number Publication Date
NO20071139L true NO20071139L (no) 2007-02-28

Family

ID=35106687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071139A NO20071139L (no) 2004-07-28 2007-02-28 Farmasoytisk preparat med langvarig frigivelse omfattende venlafaxin

Country Status (16)

Country Link
EP (1) EP1778193B1 (no)
AT (1) ATE381925T1 (no)
CY (1) CY1107187T1 (no)
DE (2) DE102004036641A1 (no)
DK (1) DK1778193T3 (no)
EA (1) EA009957B1 (no)
ES (1) ES2299061T3 (no)
HR (1) HRP20080007T3 (no)
NO (1) NO20071139L (no)
PL (1) PL1778193T3 (no)
PT (1) PT1778193E (no)
RS (1) RS50572B (no)
SI (1) SI1778193T1 (no)
UA (1) UA83437C2 (no)
WO (1) WO2006010605A2 (no)
ZA (1) ZA200701554B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722458B2 (en) * 2011-12-02 2020-07-28 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
WO2003103637A2 (en) * 2002-01-10 2003-12-18 Ranbaxy Laboratories Limited Modified release, multiple unit drug delivery systems
ZA200505180B (en) * 2002-11-28 2006-10-25 Themis Lab Private Ltd Process for manufacturing sustained release microbeads containing venlafaxine HCI

Also Published As

Publication number Publication date
UA83437C2 (uk) 2008-07-10
WO2006010605A3 (en) 2006-09-21
RS50572B (sr) 2010-05-07
WO2006010605A2 (en) 2006-02-02
DE602005004033T2 (de) 2009-01-02
CY1107187T1 (el) 2012-10-24
EP1778193B1 (en) 2007-12-26
ES2299061T3 (es) 2008-05-16
SI1778193T1 (sl) 2008-06-30
ATE381925T1 (de) 2008-01-15
EA009957B1 (ru) 2008-04-28
ZA200701554B (en) 2008-05-28
DE602005004033D1 (de) 2008-02-07
EA200700159A1 (ru) 2007-06-29
PL1778193T3 (pl) 2008-05-30
DK1778193T3 (da) 2008-02-04
PT1778193E (pt) 2008-03-10
EP1778193A2 (en) 2007-05-02
HRP20080007T3 (hr) 2008-01-31
DE102004036641A1 (de) 2006-03-23

Similar Documents

Publication Publication Date Title
JP2007302683A5 (no)
NO20091501L (no) Farmasoytiske sammensetninger
WO2009154777A3 (en) Process for preparing and drying solid rasagiline base
WO2003072025A3 (en) Modified release formulations of at least one form of tramadol
NO20081325L (no) Nye doseringsformuleringer
WO2008007152A3 (en) Preparation of pharmaceutical formulations
MX2009010280A (es) Composicion y microesfera para liberacion controlada de exendina, y metodo para preparar las mismas.
WO2005117843A3 (en) Sustained release preparations
HRP20130424T4 (hr) Postupci upotrebe sastava aminopiridina s odgođenim oslobađanjem
WO2011077451A3 (en) Controlled release pharmaceutical composition
NO20071944L (no) Hydrolysestabil beleggingsmiddelsammensetning
WO2008084698A1 (ja) タクロリムス徐放性医薬組成物
WO2006089674A3 (en) Tablets with improved drug substance dispersibility
UA99447C2 (ru) Способ получения силденафила
WO2010046932A3 (en) Extended release pharmaceutical composition of minocycline and process thereof
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
WO2010020799A3 (en) Compositions for the treatment of neoplastic diseases
TW200621307A (en) Solid dispersion composition of pranlukast with improved bioavailibility and the method of preparing the solid dispersion
DE602005004033D1 (de) Venlafaxin enthaltende pharmazeutische teilchenförmige zusammensetzung mit verzögerter freisetzung
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
WO2009013760A3 (en) Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan
WO2004026261A3 (en) Composition containing ribavirin and use thereof
UA89656C2 (ru) Фармацевтическая композиция, которая диспергируется перорально, и способ ее приготовления
WO2008015530A3 (en) Stable solid oral formulation of pantoprazole

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application